Website Disclaimer

Content marked as original on the "Infectious Disease Frontier" platform holds copyright under Infectious Disease Frontier. While we encourage sharing and reproduction of our content, it must be done with prior written consent from Infectious Disease Frontier. Unauthorized use is strictly prohibited, and legal action may be taken against infringement.
The Role of Fanconi Anemia Signaling Pathway Genes in Myelodysplastic Syndromes and Acute Myeloid Leukemia: Insights from Mutation Spectrum, Expression Profiling, and Prognosis Evaluation

The Role of Fanconi Anemia Signaling Pathway Genes in Myelodysplastic Syndromes and Acute Myeloid Leukemia: Insights from Mutation Spectrum, Expression Profiling, and Prognosis Evaluation

In November 2023, a study led by Professor XiaoFan Zhu from Chinese Academy of Medical Sciences Blood Disease Hospital (Institute of Hematology, Chinese Academy of Medical Sciences) was published in the international academic journal ——BMC Med Genomics. The title of the study is "Mutation spectrum, expression profiling, and prognosis evaluation of Fanconi anemia signaling pathway genes for 4259 patients with myelodysplastic syndromes or acute myeloid leukemia". The study sheds light on the complex interplay between Fanconi anemia (FA) signaling pathway genes and the pathogenesis of myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML).
Pediatric Acute Myeloid Leukemia and Hyperleukocytosis: Prognostic Impact of High White Blood Cell Counts

Pediatric Acute Myeloid Leukemia and Hyperleukocytosis: Prognostic Impact of High White Blood Cell Counts

In November 2023, a study led by Professor XiaoFan Zhu from Chinese Academy of Medical Sciences Blood Disease Hospital (Institute of Hematology, Chinese Academy of Medical Sciences) was published in the international academic journal ——Current Opinion In Pediatrics. The title of the study is "Pediatric acute myeloid leukemia: updates on biology, risk stratification, and therapy". The study represents a significant prognostic challenge in pediatric AML, with recent research shedding light on its complex implications for clinical outcomes.
Iron Chelation Therapy in Myelodysplastic Syndrome Mice: A Study on Erythropoiesis and Iron Overload

Iron Chelation Therapy in Myelodysplastic Syndrome Mice: A Study on Erythropoiesis and Iron Overload

In December 2023, a  study led by Professor XiaoFan Zhu from Chinese Academy of Medical Sciences Blood Disease Hospital (Institute of Hematology, Chinese Academy of Medical Sciences) was published in the international academic journal——Elife. The title of the study is "Iron chelation improves ineffective erythropoiesis and iron overload in myelodysplastic syndrome mice". The  study provides robust evidence for the effectiveness of iron chelation therapy, particularly with deferiprone (DFP), in mitigating anemia and reducing iron overload in a mouse model of myelodysplastic syndrome (MDS).
Assessment of Mortality-Related Risk Factors and Effective Antimicrobial Regimens for Treatment of Bloodstream Infections Caused by Carbapenem-Resistant Pseudomonas aeruginosa in Patients with Hematological Diseases

Assessment of Mortality-Related Risk Factors and Effective Antimicrobial Regimens for Treatment of Bloodstream Infections Caused by Carbapenem-Resistant Pseudomonas aeruginosa in Patients with Hematological Diseases

In May 2023, a  study led by Professor XiaoFan Zhu from Chinese Academy of Medical Sciences Blood Disease Hospital (Institute of Hematology, Chinese Academy of Medical Sciences) was published in the international academic journal ——Frontiers in Cellular and Infection Microbiology. The title of the study is "Assessment of mortality-related risk factors and effective antimicrobial regimens for treatment of bloodstream infections caused by carbapenem-resistant Pseudomonas aeruginosa in patients with hematological diseases". This study emphasizes the importance of identifying high-risk MDR infections and selecting appropriate antibiotic therapy to improve patient survival.
Combatting Carbapenem-Resistant Enterobacteriaceae Bloodstream Infections in Neutropenic Pediatric Hematology Patients: A Comprehensive Analysis

Combatting Carbapenem-Resistant Enterobacteriaceae Bloodstream Infections in Neutropenic Pediatric Hematology Patients: A Comprehensive Analysis

In July 2023, a  study led by Professor XiaoFan Zhu from Chinese Academy of Medical Sciences Blood Disease Hospital (Institute of Hematology, Chinese Academy of Medical Sciences) was published in the international academic journal——Antimicrobial Resistance and Infection Control. The title of the study is "High risk of bloodstream infection of carbapenem-resistant enterobacteriaceae carriers in neutropenic children with hematological diseases". The analysis underscores the critical threat posed by carbapenem-resistant Enterobacteriaceae (CRE) bloodstream infections (BSIs) in neutropenic pediatric hematology patients.
Measurable Residual Disease in Leukemia: Improving Qualification through MRDworst case

Measurable Residual Disease in Leukemia: Improving Qualification through MRDworst case

In November 2023, a  study led by Professor XiaoFan Zhu from Chinese Academy of Medical Sciences Blood Disease Hospital (Institute of Hematology, Chinese Academy of Medical Sciences) was published in the international academic journal——Leukemia（11.4）. The title of the study is "Have we been qualifying measurable residual disease correctly?". The comparative analysis between MRDworst case and MRDconventional methodologies reveals a clear advantage in favor of the former, particularly in its capacity to enhance the accuracy of relapse risk prediction in leukemia patients.
Advancing Prognostic Assessment in Pediatric Acute Myeloid Leukemia with KMT2A Rearrangement: Integrating Transcriptomic Profiling

Advancing Prognostic Assessment in Pediatric Acute Myeloid Leukemia with KMT2A Rearrangement: Integrating Transcriptomic Profiling

In November 2023, a study led by Professor XiaoFan Zhu from Chinese Academy of Medical Sciences Blood Disease Hospital (Institute of Hematology, Chinese Academy of Medical Sciences) was published in the international academic journal ——Hemasphere. The title of the study is "Integration of Transcriptomic Features to Improve Prognosis Prediction of Pediatric Acute Myeloid Leukemia With KMT2A Rearrangement". The study represents a significant advancement in the prognostic assessment of pediatric acute myeloid leukemia (AML) with KMT2A rearrangement.